DWA
AUGX

Dorsey Wright & Associates’s Augmedix, Inc. Common Stock AUGX Stock Holding History

Dorsey Wright & Associates’s Portfolio AUGX Stock Details AUGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-5,370
Closed -$27.7K – 300
2023
Q3 		$27.7K Sell
5,370
-185
-3% -$868 0.01% 189
2023
Q2 		$26.7K Buy
+5,555
New +$19.2K 0.01% 194

Other funds holding AUGX

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
SM
Samjo Management New York $231M AUM 13.04% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
GIPM
G2 Investment Partners Management New York $406M AUM 164.47% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
AFG
American Financial Group Cincinnati, Ohio $270M AUM 3.25% 1-Year Est. Return

Dorsey Wright & Associates's AUGX Position: Q4 2023 in Review

Dorsey Wright & Associates sold out of Augmedix, Inc. Common Stock (AUGX) in Q4 2023, closing a stake of 5,370 shares — an estimated $27.7K sold.

Dorsey Wright & Associates first reported a position in AUGX in Q2 2023 and held it in 2 quarters. The position peaked at $27.7K in Q3 2023. 85 funds tracked by Wall St. Rank hold AUGX as of Q4 2023.

  • Dorsey Wright & Associates reported no remaining Augmedix, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Dorsey Wright & Associates sold 5,370 Augmedix, Inc. Common Stock shares in Q4 2023, an estimated $27.7K.
  • Dorsey Wright & Associates first reported a position in Augmedix, Inc. Common Stock in Q2 2023 and held it in 2 quarters.
  • Dorsey Wright & Associates's Augmedix, Inc. Common Stock position peaked at $27.7K in Q3 2023.
  • 85 funds tracked by Wall St. Rank held Augmedix, Inc. Common Stock as of Q4 2023.

Based on Dorsey Wright & Associates's 13F filing for Q4 2023, filed 13 Feb 2024.